| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f28f3571e842c96b35ffe5a3ea4a2a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf80785b2dcca083534e19e9f9172751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e65659a94131d0ad6c29212eef191d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_252495c92ce1344599a276b5441f5348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40d60ca869f09093e64a5b8371bea0fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 |
| filingDate |
2009-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7a85c7669e1e333eeb6aaff76258f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d30754e611fea4027da3ff50fee02e29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7150528587166ac79b28d80ecf41207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6af8ab321b77d1284777d2de34c5cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1fbd6d4e2276ace37be83f7b8b23a56 |
| publicationDate |
2014-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8703770-B2 |
| titleOfInvention |
Pyridazine carboxamide orexin receptor antagonists |
| abstract |
The present invention is directed to pyridazine carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11661401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739093-B2 |
| priorityDate |
2008-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |